We've got a sneak peek at what’s inside CURE®'s 2019 Genitourinary Cancers special issue.
Hi, I’m Jessica Skarzynski for CURE Magazine®, your guide to every stage of the cancer experience.
Here’s a look at what’s inside our 2019 Genitourinary Cancers special issue:
Active surveillance has become the gold standard for low-risk prostate cancer, but challenges remain. What new diagnostic tools can be used to make it more precise? In this issue’s cover story, we delve deeper into how experts are Polishing the Gold Standard.
Next, when it comes to treating kidney cancer — more may be better. A One-Two Punchapproach, with immunotherapy and targeted treatment, offers a better alternative to single agents.